SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Albireo Pharma Inc Says Trial Did Not Achieve Proof-of-Concept For Other Key Nash Measures; Says Trial Showed Unremarkable Results In Key Nash Measures

Benzinga · 08/18/2020 20:46